Exercise for Prostate Cancer Patients - Full Text View

Exercise for Prostate Cancer Patients (EXCAP)

This study is currently recruiting participants.

Verified by University of Rochester, February 2009

First Received: December 29, 2008 Last Updated: February 25, 2009 History of Changes

Sponsor:	University of Rochester
Collaborator:	Department of Defense
Information provided by:	University of Rochester
ClinicalTrials.gov Identifier:	NCT00815672

Purpose

The purpose of this study is to gain a better understanding of the mechanisms responsible for cancer-related fatigue.

Condition	Intervention
Prostate Cancer Related Fatigue	Behavioral: Exercise

Study Type:	Interventional
Study Design:	Supportive Care, Randomized, Single Blind (Investigator), Parallel Assignment, Efficacy Study
Official Title:	The Influence of Home-Based Aerobic and Resistance Exercise on Cancer-Related Fatigue, Strength, and Muscle Mass in Prostate Patients During Radiotherapy

Resource links provided by NLM:

MedlinePlus related topics: Cancer Exercise and Physical Fitness Prostate Cancer

U.S. FDA Resources

Further study details as provided by University of Rochester:

Primary Outcome Measures:

Cancer-related fatigue [ Time Frame: 4.5 Months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

To provide preliminary data on influence of home-based aerobic and resistance exercise on strength, skeletal muscle mass, inflammatory response, QOL and it's relationship to CRF [ Time Frame: 4.5 months ] [ Designated as safety issue: No ]

Estimated Enrollment:	122
Study Start Date:	December 2007
Estimated Primary Completion Date:	May 2010 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Treatment Arm 1: No Intervention Usual Care: Standard care monitoring
Treatment arm 2: Experimental Home-based Exercise: Progressive walking and resistance exercise treatment.	Behavioral: Exercise Progressive walking and resistance exercise treatment

Show Detailed Description

Eligibility

Ages Eligible for Study:	21 Years and older
Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Have a primary diagnosis of prostate cancer, with no distant metastasis or recurrent disease.
Have a KPS of 60 or greater.
Be scheduled for at least 28 total radiation treatments without concurrent chemotherapy or interferon treatments.
Have approval of physician and be able to read English.
Be 21 years of age or older and give informed consent

Exclusion Criteria:

Have had previous radiation for cancer treatment within the last 2 years.
Have metastatic disease or physical limitations.They also should not be identified as active or maintenance stage of exercise behavior.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00815672

Contacts

Contact: Karen Mustian, Ph.D.

585-273-1796

karen_mustian@urmc.rochester.edu

Locations

United States, New York
James P. Wilmot Cancer Center, University of Rochester	Recruiting
Rochester, New York, United States, 14642
Contact: Ann Colasurdo 585-276-4059 ann_colasurdo@urmc.rochester.edu
Contact: Caitlin Maska 585-275-7091 caitlin_maska@urmc.rochester.edu
Principal Investigator: Karen Mustian, Ph.D.

Sponsors and Collaborators

University of Rochester

Department of Defense

Investigators

Principal Investigator:

Karen Mustian, Ph.D.

James P. Wilmot Cancer Center, University of Rochester

More Information

No publications provided

Responsible Party:	University of Rochester ( Karen Mustian Ph.D. )
Study ID Numbers:	1703DOD
Study First Received:	December 29, 2008
Last Updated:	February 25, 2009
ClinicalTrials.gov Identifier:	NCT00815672 History of Changes
Health Authority:	United States:Department of Defense

Keywords provided by University of Rochester:

Exercise
Prostate cancer
Fatigue

Additional relevant MeSH terms:

Signs and Symptoms
Neoplasms
Neoplasms by Site
Fatigue
Prostatic Diseases

Genital Neoplasms, Male
Urogenital Neoplasms
Genital Diseases, Male
Prostatic Neoplasms

ClinicalTrials.gov processed this record on November 27, 2009